AmCad BioMed Corporation

NT$14.25As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4188Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (6.80%)
Div yield —
ROE (11.18%)
Medical Devices
Beta (5Y) 0.36
PE TTM —
TSR TTM (10.66%)
Mkt cap NT$902.5M
ROIC (8.82%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$15
7.02%
(43.15%)
Buy 12|10|9|5|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.17
0.19
0.19
0.20
(8.23%)
4.51%
5.35%
15.22%
RevenueNT$M
41.22
42.15
44.23
44.84
(0.61%)
2.51%
7.77%
7.43%
Peers (US$27.26M)
Cap (US$)
PE
28.11M
—
Capital
TTM
5Y
10Y
Leveragex
1.265
—
—
EBIT/Intx
1.443
0.948
0.836
Own earn%
251.94
35.80
34.40
Sh yield%
52.45
40.03
40.31
Owners
Insiders/Inst%
2.05
52.37
Short interest%
0.91
SBC / revenue%
0.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
28–33
$1 testx
0.3
Incr. ROIC%
22